Arthralgia during anastrozole therapy for breast cancer

Study identifier:D5392L00013

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Multicentre, Open Study Assessing Joint Disorders Under ARIMIDEX® (1mg/day) as Adjuvant Treatment in Post Menopausal Women with Early Breast Cancer

Medical condition

Early Breast Cancer

Phase

Phase 4

Healthy volunteers

No

Study drug

Anastrozole

Sex

Female

Actual Enrollment

114

Study type

Interventional

Age

18 Years +

Date

Study Start Date: 01 Jun 2006
Primary Completion Date: 01 Jan 2009
Study Completion Date: 01 Jan 2009

Study design

Allocation: Non-randomized
Endpoint Classification: Safety Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment

Verification:

Verified 01 Mar 2012 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria